Document is current
Any future updates will be listed below
-
Authors
Qi, Jingjing https://orcid.org/0000-0002-5224-4416
Zhao, Xiangge
Gao, Xiaoyu
Zhu, Xiaolu
Wang, Junli
Liu, Jiaqing
Wei, Jing
Li, Xia
Gao, Bihu
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82201990)
National Natural Science Foundation of China (82271839)
China Postdoctoral Science Foundation (2023M730449)
- License Information
-
More Information
Article History
Received: 23 March 2025
Accepted: 7 July 2025
First Online: 16 July 2025
Declarations
:
: The study was approved by the ethics committee of The Second Hospital of Dalian Medical University (2023 − 253, approval date: 8 October 2023). Title of the approved project: Study on pathogenesis and immunotherapy of patients with autoimmune diseases. The patients or their guardians or legally authorized representatives provided written informed consent for the use of the blood samples or UC-MSCs. The animal experiment was approved by the Animal Ethical Committee of Dalian Medical University (AEE24013, approval date: 16 May 2024). Title of the approved project: Study on pathogenesis and treatment of autoimmune diseases. Liaoning Changsheng Biological Co., LTD (CSE2023011005, approval date: 30 August 2023). Title of the approved project: Study on pathogenesis and treatment of Sjögren’s syndrome and systemic lupus erythematosus.
: Not applicable.
: The authors declare that they have no competing interests.
